TP53 and inflammatory bowel disease: Thus, we performed this pilot study to evaluate the concentrations of proapoptotic p53, cytochrome c, and caspase 9 and the level of antiapoptotic Bcl-2 in healthy volunteers and IBD patients with respect to the disease type, activity, and treatment.